Periodic Reporting for period 1 - CanFaster (The Translational Cancer Faster Forward doctoral programme – CanFaster)
Reporting period: 2017-06-01 to 2019-05-31
The CanFaster programme is enabled by an intimate collaboration between industry, health care system and academia (in total ~7 million Euro will be invested), and will contribute to the Europe 2020 strategy, where one million new research jobs are needed to reach the Innovation Union flagship initiative. The collected track record of all partners in the proposed CanFaster programme demonstrates an impressive history of entrepreneurial spirit, state-of the art medical care but also truly world-class scientific excellence within translational cancer research. The CanFaster regional doctoral programme, has recruited 16 ESRs, that are hosted within CREATE Health, a translational cancer research programme with broad international collaboration partners and excellent out-put for the last 10 years.
The main objectives of CanFaster program are (i) increased international and intersectoral mobility, (ii) intensified collaboration within oncology between different sectors including academia, industry and health care, (iii) acceleration of innovation, attracting international investors leading to increased number of SMEs in the region and (iv) education of a new generation of excellent multidisciplinary, entrepreneurial scientists. This is achieved through the attraction of the MSCA program for industrial partners to add-on to the EU and public national funding of the programme with financial and in-kind contribution.
The doctoral training within CanFaster is divided into four parallel work packages, e.g. scientific training in cancer research, CanFaster specific training, intersectoral, international training and LU specific mandatory training. The work packages are tailor-made to each ESR. However, the basic framework is provided by LU to ensure that the ESRs fulfill the criteria for doctoral degree defined by the Higher Education Ordinance in Sweden. The CanFaster programme will offer several courses within IP, commercialization and clinical implementation as well as secondments in industry or clinical setting.